MOLN
Molecular PartnersDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
MOLN vs peer average
50/100
MOLN vs. peer average (D vs. D)
Grade spread
A 1 · C 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
SPRO is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $163.86M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MOLN
Molecular Partners
SPRO
Spero Therapeutics
Grade
D
F
Momentum
38
5
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs SPRO
MOLN / SPRO
Grade Position
In line
MOLN vs. peer average (D vs. D)
50/100
Momentum
38
MOLNValue
41
MOLNSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MOLN
SPRO is the first peer returned for this comparison set.

